101 related articles for article (PubMed ID: 20465659)
1. Cutaneous vascular patterns in psoriasis.
Micali G; Lacarrubba F; Musumeci ML; Massimino D; Nasca MR
Int J Dermatol; 2010 Mar; 49(3):249-56. PubMed ID: 20465659
[TBL] [Abstract][Full Text] [Related]
2. In vivo quantification of microvessels in clinically uninvolved psoriatic skin and in normal skin.
Hern S; Mortimer PS
Br J Dermatol; 2007 Jun; 156(6):1224-9. PubMed ID: 17459047
[TBL] [Abstract][Full Text] [Related]
3. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase in psoriatic epidermis.
Creamer D; Jaggar R; Allen M; Bicknell R; Barker J
Br J Dermatol; 1997 Dec; 137(6):851-5. PubMed ID: 9470899
[TBL] [Abstract][Full Text] [Related]
5. Topical application of anti-angiogenic peptides based on pigment epithelium-derived factor can improve psoriasis.
Abe R; Yamagishi S; Fujita Y; Hoshina D; Sasaki M; Nakamura K; Matsui T; Shimizu T; Bucala R; Shimizu H
J Dermatol Sci; 2010 Mar; 57(3):183-91. PubMed ID: 20060688
[TBL] [Abstract][Full Text] [Related]
6. T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vitro via secreted products.
Prinz JC; Gross B; Vollmer S; Trommler P; Strobel I; Meurer M; Plewig G
Eur J Immunol; 1994 Mar; 24(3):593-8. PubMed ID: 8125129
[TBL] [Abstract][Full Text] [Related]
7. Nature of cell kinetics in psoriatic epidermis.
Doger FK; Dikicioglu E; Ergin F; Unal E; Sendur N; Uslu M
J Cutan Pathol; 2007 Mar; 34(3):257-63. PubMed ID: 17302610
[TBL] [Abstract][Full Text] [Related]
8. Fluorescent fibre-optic confocal imaging of lesional and non-lesional psoriatic skin compared with normal skin in vivo.
Suihko C; Serup J
Skin Res Technol; 2012 Nov; 18(4):397-404. PubMed ID: 22111991
[TBL] [Abstract][Full Text] [Related]
9. [The role of cytokines for the pathogenesis of psoriasis].
Kapp A
Hautarzt; 1993 Apr; 44(4):201-7. PubMed ID: 8482597
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of psoriasis.
Kadunce DP; Krueger GG
Dermatol Clin; 1995 Oct; 13(4):723-37. PubMed ID: 8785878
[TBL] [Abstract][Full Text] [Related]
11. Psoriasis: the epidermal component.
Tschachler E
Clin Dermatol; 2007; 25(6):589-95. PubMed ID: 18021897
[TBL] [Abstract][Full Text] [Related]
12. Phosphodiesterase 7A inhibitor ASB16165 impairs proliferation of keratinocytes in vitro and in vivo.
Goto M; Kadoshima-Yamaoka K; Murakawa M; Yoshioka R; Tanaka Y; Inoue H; Murafuji H; Kanki S; Hayashi Y; Nagahira K; Ogata A; Nakatsuka T; Fukuda Y
Eur J Pharmacol; 2010 May; 633(1-3):93-7. PubMed ID: 20132810
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis mediated by cytolytic molecules might be responsible for maintenance of psoriatic plaques.
Kastelan M; Massari LP; Brajac I
Med Hypotheses; 2006; 67(2):336-7. PubMed ID: 16563649
[TBL] [Abstract][Full Text] [Related]
14. Effective therapy with anti-TNF-alpha in patients with psoriatic arthritis is associated with decreased levels of metalloproteinases and angiogenic cytokines in the sera and skin lesions.
Cordiali-Fei P; Trento E; D'Agosto G; Bordignon V; Mussi A; Ardigó M; Mastroianni A; Vento A; Solivetti F; Berardesca E; Ensoli F
Ann N Y Acad Sci; 2007 Sep; 1110():578-89. PubMed ID: 17911474
[TBL] [Abstract][Full Text] [Related]
15. Angiogenic properties of normal and psoriatic skin associate with epidermis, not dermis.
Malhotra R; Stenn KS; Fernandez LA; Braverman IM
Lab Invest; 1989 Aug; 61(2):162-5. PubMed ID: 2474089
[TBL] [Abstract][Full Text] [Related]
16. Role of Angiogenic Growth Factors in Psoriasis: A Review.
Akhtar T; Wani WY; Kamal MA; Kaur R
Curr Drug Metab; 2018; 19(11):910-916. PubMed ID: 29663878
[TBL] [Abstract][Full Text] [Related]
17. Resident skin cells in psoriasis: a special look at the pathogenetic functions of keratinocytes.
Albanesi C; De Pità O; Girolomoni G
Clin Dermatol; 2007; 25(6):581-8. PubMed ID: 18021896
[TBL] [Abstract][Full Text] [Related]
18. Vasoactive intestinal peptide and inflammatory cytokines enhance vascular endothelial growth factor production from epidermal keratinocytes.
Kakurai M; Demitsu T; Umemoto N; Kobayashi Y; Inoue-Narita T; Fujita N; Ohtsuki M; Furukawa Y
Br J Dermatol; 2009 Dec; 161(6):1232-8. PubMed ID: 19785602
[TBL] [Abstract][Full Text] [Related]
19. Cytokine system as potential target for antipsoriatic therapy.
Kemény L; Michel G; Dobozy A; Ruzicka T
Exp Dermatol; 1994 Feb; 3(1):1-8. PubMed ID: 8061931
[TBL] [Abstract][Full Text] [Related]
20. T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells.
Vollmer S; Menssen A; Trommler P; Schendel D; Prinz JC
Eur J Immunol; 1994 Oct; 24(10):2377-82. PubMed ID: 7925564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
